English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

On 31 December 2019, a cluster of pneumonia cases with unknown etiology was reported in Wuhan city, Hubei province of China. A novel coronavirus (SARS-CoV2) was later detected as the causative agent and the clinical condition was called coronavirus disease 19 (COVID-19). The SARS-CoV-2 infection has a wide clinical course that can progress from mild symptoms such as fever, sore throat, cough to pneumonia and acute severe respiratory failure. The S protein of SARS-CoV-2 is thought to bind to the host cell angiotensin-converting enzyme 2 (ACE2) receptor and cause the disease.

Hyponatremia in COVID-19 patient using angiotensin type 1 receptor (AT1R) blocker and diuretic: a case report